Literature DB >> 23675778

Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer.

Andrei E Medvedev1.   

Abstract

Toll-like receptors (TLRs) are germ-line-encoded innate immune sensors that recognize conserved microbial structures and host alarmins and signal expression of MHC proteins, costimulatory molecules, and inflammatory mediators by macrophages, neutrophils, dendritic cells, and other cell types. These processes activate immediate and early mechanisms of innate host defense, as well as initiate and orchestrate adaptive immune responses. Several single-nucleotide polymorphisms (SNPs) within the TLR genes have been associated with altered susceptibility to infectious, inflammatory, and allergic diseases, and have been found to play a role in tumorigenesis. Critical advances in our understanding of innate immune functions and genome-wide association studies (GWAS) have uncovered complex interactions of genetic polymorphisms within TLRs and environmental factors. However, conclusions obtained in the course of such analyses are restricted by limited power of many studies that is likely to explain controversial findings. Further, linkages to certain ethnic backgrounds, gender, and the presence of multigenic effects further complicate the interpretations of how the TLR SNPs affect immune responses. For many TLRs, the molecular mechanisms by which SNPs impact receptor functions remain unknown. In this review, I have summarized current knowledge about the TLR polymorphisms, their impact on TLR signaling, and associations with various inflammatory, infectious, allergic diseases and cancers, and discussed the directions of future scientific research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23675778      PMCID: PMC3760066          DOI: 10.1089/jir.2012.0140

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  257 in total

1.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

Authors:  Seung-Yong Seong; Polly Matzinger
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

2.  An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population.

Authors:  E Noguchi; F Nishimura; H Fukai; J Kim; K Ichikawa; M Shibasaki; T Arinami
Journal:  Clin Exp Allergy       Date:  2004-02       Impact factor: 5.018

3.  A common polymorphism in TLR3 confers natural resistance to HIV-1 infection.

Authors:  Manuela Sironi; Mara Biasin; Rachele Cagliani; Diego Forni; Mariacristina De Luca; Irma Saulle; Sergio Lo Caputo; Francesco Mazzotta; Juan Macías; Juan A Pineda; Antonio Caruz; Mario Clerici
Journal:  J Immunol       Date:  2011-12-14       Impact factor: 5.422

4.  The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia.

Authors:  M J Newport; A Allen; A A Awomoyi; S J Dunstan; E McKinney; A Marchant; G Sirugo
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

5.  The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses.

Authors:  Vijay A K Rathinam; Zhaozhao Jiang; Stephen N Waggoner; Shruti Sharma; Leah E Cole; Lisa Waggoner; Sivapriya Kailasan Vanaja; Brian G Monks; Sandhya Ganesan; Eicke Latz; Veit Hornung; Stefanie N Vogel; Eva Szomolanyi-Tsuda; Katherine A Fitzgerald
Journal:  Nat Immunol       Date:  2010-03-28       Impact factor: 25.606

6.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta.

Authors:  Jonathan C Kagan; Tian Su; Tiffany Horng; Amy Chow; Shizuo Akira; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2008-02-24       Impact factor: 25.606

Review 7.  Functional consequences of toll-like receptor 4 polymorphisms.

Authors:  Bart Ferwerda; Matthew Bb McCall; Karlijn Verheijen; Bart-Jan Kullberg; André Jam van der Ven; Jos Wm Van der Meer; Mihai G Netea
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

8.  Association of polymorphisms of toll-like receptor 4 with a reduced prevalence of hay fever and atopy.

Authors:  Ambikaipakan Senthilselvan; Donna Rennie; Liliane Chénard; Lauranell H Burch; Lorne Babiuk; David A Schwartz; James A Dosman
Journal:  Ann Allergy Asthma Immunol       Date:  2008-05       Impact factor: 6.347

9.  Double-stranded RNA-mediated TLR3 activation is enhanced by CD14.

Authors:  Hyun-Ku Lee; Stefan Dunzendorfer; Katrin Soldau; Peter S Tobias
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

10.  Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy.

Authors:  E Schott; H Witt; K Neumann; A Bergk; J Halangk; V Weich; T Müller; G Puhl; B Wiedenmann; T Berg
Journal:  J Viral Hepat       Date:  2008-01       Impact factor: 3.728

View more
  44 in total

Review 1.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

2.  Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.

Authors:  Michael E Lindquist; Xiankun Zeng; Louis A Altamura; Sharon P Daye; Korey L Delp; Candace Blancett; Kayla M Coffin; Jeffrey W Koehler; Susan Coyne; Charles J Shoemaker; Aura R Garrison; Joseph W Golden
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

Review 3.  Early life factors that affect allergy development.

Authors:  Lisa A Reynolds; B Brett Finlay
Journal:  Nat Rev Immunol       Date:  2017-05-15       Impact factor: 53.106

Review 4.  Organ system view of the hepatic innate immunity in HCV infection.

Authors:  Bo-Ram Bang; Sandra Elmasry; Takeshi Saito
Journal:  J Med Virol       Date:  2016-05-13       Impact factor: 2.327

Review 5.  Cell Signaling Pathways That Regulate Antigen Presentation.

Authors:  Randy R Brutkiewicz
Journal:  J Immunol       Date:  2016-10-15       Impact factor: 5.422

6.  The Arg753Gln Polymorphism of Toll-Like Receptor 2 Has a Lower Occurrence in Patients with Syphilis, Suggesting Its Protective Effect in Czech and Slovak Individuals.

Authors:  Linda Grillová; Jana Musilová; Klára Janečková; Petra Pospíšilová; Ivana Kuklová; Vladana Woznicová; Hana Zákoucká; David Šmajs
Journal:  Infect Immun       Date:  2020-12-15       Impact factor: 3.441

Review 7.  TLRs in Mycobacterial Pathogenesis: Black and White or Shades of Gray.

Authors:  Priyanka Mehta; Atish Ray; Shibnath Mazumder
Journal:  Curr Microbiol       Date:  2021-04-12       Impact factor: 2.188

8.  Association between small intestinal bacterial overgrowth and toll-like receptor 4 in patients with pancreatic carcinoma and cholangiocarcinoma.

Authors:  Xiaoying Ma; Heju Wang; Peng Zhang; Lin Xu; Zibin Tian
Journal:  Turk J Gastroenterol       Date:  2019-02       Impact factor: 1.852

9.  Polymorphisms of glutathione S-transferase π 1 and toll-like receptors 2 and 9: Association with breast cancer susceptibility.

Authors:  Mohammad F Al-Harras; Maha E Houssen; Mohamed E Shaker; Kamel Farag; Omar Farouk; Rehan Monir; Rasha El-Mahdy; Ekbal M Abo-Hashem
Journal:  Oncol Lett       Date:  2016-01-28       Impact factor: 2.967

10.  Blood-stage malaria of Plasmodium chabaudi induces differential Tlr expression in the liver of susceptible and vaccination-protected Balb/c mice.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Suliman Alomar; Abdel Azeem S Abdel-Baki; Denis Delic; Frank Wunderlich; Marcos J Araúzo-Bravo
Journal:  Parasitol Res       Date:  2016-01-25       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.